Overview

Update
IPO / Stock
Went Public on Oct 20, 1995 / NASDAQ:OGXI
Total Equity Funding
$34.3M in 3 Rounds from 4 Investors
Headquarters:
Bothell, Washington
Description:
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://oncogenex.com
Social:

Company Details

Update
Founded:
Unknown
Aliases:
ONCOGENEX PHARMACEUTICALS, INC.
Contact:
4256861500
Employees:
51 - 100 | 2 in Crunchbase

OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Funding Rounds (3) - $34.3M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2010$10M / Venture0
Aug, 2005$12.8M / Series B0
Oct, 2003$11.5M / Series B4

Current Team (2)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Office

    1522 217th Place SE

    Suite 100

    Bothell, Washington 98021

    United States

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos